16-28866173-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001387430.1(SH2B1):c.79C>T(p.Arg27Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,516,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
SH2B1
NM_001387430.1 missense
NM_001387430.1 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 0.262
Genes affected
SH2B1 (HGNC:30417): (SH2B adaptor protein 1) This gene encodes a member of the SH2-domain containing mediators family. The encoded protein mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular transformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.25074342).
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2B1 | NM_001387430.1 | c.79C>T | p.Arg27Trp | missense_variant | 1/8 | ENST00000684370.1 | NP_001374359.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000595 AC: 9AN: 151316Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
151316
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000428 AC: 7AN: 163580Hom.: 0 AF XY: 0.0000556 AC XY: 5AN XY: 89866
GnomAD3 exomes
AF:
AC:
7
AN:
163580
Hom.:
AF XY:
AC XY:
5
AN XY:
89866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000286 AC: 39AN: 1365306Hom.: 0 Cov.: 37 AF XY: 0.0000340 AC XY: 23AN XY: 675754
GnomAD4 exome
AF:
AC:
39
AN:
1365306
Hom.:
Cov.:
37
AF XY:
AC XY:
23
AN XY:
675754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000528 AC: 8AN: 151424Hom.: 0 Cov.: 32 AF XY: 0.0000541 AC XY: 4AN XY: 73992
GnomAD4 genome
AF:
AC:
8
AN:
151424
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
73992
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
SH2B1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2024 | The SH2B1 c.79C>T variant is predicted to result in the amino acid substitution p.Arg27Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.014% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 27 of the SH2B1 protein (p.Arg27Trp). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SH2B1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;L;L;L
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;.;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;.;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
0.99, 0.95
.;D;P;.;D;P;P
Vest4
0.49, 0.36, 0.49, 0.47, 0.48
MutPred
Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);Loss of phosphorylation at S32 (P = 0.1218);
MVP
MPC
0.81
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at